Cointime update: SRTD Biotech, a Jülich, Germany-based mRNA therapeutics startup, closed a €31.5 million seed round on November 9, oversubscribed. Mérieux Equity Partners led via its Mérieux Innovation 2 fund, with NRW.BANK and Boehringer Ingelheim Venture Fund co-leading; Lilly Ventures, HTGF and Anobis Asset also participated. The company also named Matthias Alder CEO, Heinz Koeppl CTO and Jens Hennecke CBO.
German mRNA startup SRTD Biotech raises €31.5M seed round
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
13m ago
DWF Labs: Binance Hack Shows No Broad Contagion, 24h Net Outflow Falls to $458M
23m ago
Elliptic: Binance Hacker Laundered $430K via Self-Made Meme Coins
25m ago
Fixed-Rate Lending Protocol IRIS to Launch on SparkLend Nov 10
26m ago
Bain Capital’s 2004 Kiva bet returned 26.6x after Amazon acquisition
31m ago
Mercado Bitcoin Begins Phased Access Restoration, Customers Can Only View Balances
34m ago
BitMine Holds 6.07M ETH, 4.97% of Total Supply